Topical rapamycin and microcystic lymphatic malformations

J Am Acad Dermatol. 2024 Jan;90(1):e29-e30. doi: 10.1016/j.jaad.2023.06.066. Epub 2023 Sep 17.

Authors

Yaron Gu¹, Deshan F Sebaratnam²

Affiliations

¹ Department of Dermatology, Liverpool Hospital, Liverpool, Australia; Faculty of Medicine, University of New South Wales, Kensington, Australia.
² Department of Dermatology, Liverpool Hospital, Liverpool, Australia; Faculty of Medicine, University of New South Wales, Kensington, Australia. Electronic address: [email protected].

PMID: 37717734
DOI: 10.1016/j.jaad.2023.06.066

No abstract available

Keywords: lymphatic malformation; rapamycin; sirolimus; topical; vascular anomalies; verrucous venous malformation.

Publication types

Letter
Comment

MeSH terms

Humans
Immunosuppressive Agents
Lymphatic Abnormalities* / drug therapy
Sirolimus / therapeutic use
Treatment Outcome
Vascular Malformations*

Substances

Immunosuppressive Agents
Sirolimus